FectoVIR®-AAV悬浮系统生产AAV价格_品牌:Polyplus-丁香通官网

库存：现货

英文名：FectoVIR®-AAV

CAS号：/

保质期：/

供应商：纽祺（上海）健康科技有限公司

保存条件：5±3℃

规格：1ml

Superior Performance: highest AAV titers for increased number of doses per batch 卓越的性能:最高的AAV滴度增加剂量的批次
Scalable: robust and flexible to support small to large scale production 可扩展:健壮和灵活，支持小到大规模的生产
Cost-effective: reduced cost per dose for therapy affordability 成本效益:降低每剂治疗的成本
Accelerated time to market: performance and scalability for faster process development 加速上市时间:更快流程开发的性能和可伸缩性

Trustworthy: #1 transfection supplier of Gene & Cell therapy 值得信赖:基因和细胞治疗的头号转染供应商

Overview（概述）

Specifications（规范）

Reagent 试剂	FectoVIR^®-AAV
Molecule delivered 转染核酸	Plasmid DNA and co-delivery of several plasmid DNA 质粒DNA，多质粒DNA的共转
Applications 应用	Recombinant AAV virus production in suspension cells 在悬浮细胞中生产重组 AAV 病毒
Virus types 病毒类型	Adeno-Associated Viruses (AAV) 腺相关病毒 (AAV)
Cell types 细胞类型	Mammalian producer cell lines (HEK-293, HEK-293 derivatives) grown in suspension cultures 悬浮培养的哺乳动物细胞系(HEK-293, HEK-293系)
Number of transfections 试剂用量	100 mL of FectoVIR^®-AAV transfection reagent is sufficient to transfect on average 50 L of cell culture 100 mL的FectoVIR^®-AAV 至少转染50 L培养液
Storage 储存条件	5 ± 3 °C, stable for at least 9 months when stored appropriately 5 ± 3 °C, 至少18 个月
Provided with 配套提供	Protocol Certificate of Analysis Certificate of Origin Non-Hazardous Product Statement 操作说明书 COA分析报告无动物来源声明无危害声明

Summary（总结）

AAVs are becoming the leading viral vector in the development of gene-based advanced therapy medicinal products (ATMPs). Their success is due to their intrinsic properties: they are primarily non-integrating as they persist within cells as episomes, and have a broad tropism with eleven serotypes that have the ability to infect specific cell types. A major challenge today is manufacturing sufficient quantities of AAV in order to treat larger groups of patients. FectoVIR^®-AAV is a novel class of animal free transfection reagent specifically developed for industrial scale production of recombinant AAV (rAAV) viral vectors in suspension HEK-293 cell types. FectoVIR^®-AAV transfection reagent guarantees higher rAAV viral titers, improved flexibility and scalability for industrial scale manufacturing.
aav正在成为基于基因的先进治疗药物(ATMPs)开发的主要病毒载体。它们的成功是由于它们的内在特性:它们主要是不整合的，因为它们以集集体的形式存在于细胞内，并具有广泛的趋同性，具有感染特定细胞类型的能力的11种血清型。今天的一个主要挑战是生产足够数量的AAV，以治疗更大的患者群体。FectoVIR®-AAV是一种新型的动物无转染试剂，专门开发用于工业规模生产重组AAV (rAAV)病毒载体悬浮HEK-293细胞类型。FectoVIR®-AAV转染试剂保证了更高的rAAV病毒滴度，提高了工业规模生产的灵活性和可扩展性。

A Frequently Asked Question section about FectoVIR^®-AAV can be found here.
关于FectoVIR®-AAV的常见问题可以在这里找到。
Read FAQ（阅读常见问题）